Agenus Inc (AGEN)
4.97
-0.43
(-7.96%)
USD |
NASDAQ |
Apr 18, 16:00
5.00
+0.03
(+0.60%)
After-Hours: 20:00
Agenus Total Liabilities (Quarterly): 462.30M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 462.30M |
September 30, 2023 | 450.76M |
June 30, 2023 | 460.35M |
March 31, 2023 | 465.96M |
December 31, 2022 | 468.46M |
September 30, 2022 | 440.86M |
June 30, 2022 | 442.54M |
March 31, 2022 | 413.66M |
December 31, 2021 | 418.05M |
September 30, 2021 | 402.09M |
June 30, 2021 | 448.05M |
March 31, 2021 | 432.86M |
December 31, 2020 | 426.01M |
September 30, 2020 | 410.81M |
June 30, 2020 | 411.75M |
March 31, 2020 | 382.56M |
December 31, 2019 | 386.67M |
September 30, 2019 | 379.68M |
June 30, 2019 | 368.32M |
March 31, 2019 | 365.22M |
December 31, 2018 | 310.95M |
September 30, 2018 | 261.87M |
June 30, 2018 | 245.02M |
March 31, 2018 | 244.05M |
December 31, 2017 | 214.22M |
Date | Value |
---|---|
September 30, 2017 | 200.86M |
June 30, 2017 | 193.97M |
March 31, 2017 | 194.36M |
December 31, 2016 | 196.11M |
September 30, 2016 | 195.88M |
June 30, 2016 | 179.58M |
March 31, 2016 | 176.69M |
December 31, 2015 | 171.50M |
September 30, 2015 | 165.63M |
June 30, 2015 | 92.92M |
March 31, 2015 | 71.07M |
December 31, 2014 | 51.51M |
September 30, 2014 | 38.76M |
June 30, 2014 | 42.56M |
March 31, 2014 | 45.02M |
December 31, 2013 | 39.32M |
September 30, 2013 | 40.55M |
June 30, 2013 | 38.63M |
March 31, 2013 | 47.82M |
December 31, 2012 | 46.69M |
September 30, 2012 | 45.38M |
June 30, 2012 | 44.63M |
March 31, 2012 | 43.84M |
December 31, 2011 | 40.64M |
September 30, 2011 | 40.44M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
368.32M
Minimum
Jun 2019
468.46M
Maximum
Dec 2022
424.83M
Average
426.01M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
Protalix BioTherapeutics Inc | 50.86M |
InfuSystems Holdings Inc | 50.61M |
PAVmed Inc | 57.14M |
Allogene Therapeutics Inc | 130.60M |
Pfizer Inc | 137.21B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 313.91M |
Shareholders Equity (Quarterly) | -160.33M |
Debt to Equity Ratio | -0.0805 |
Current Ratio | 0.4393 |
Net Debt Paydown Yield | 0.03% |